Doxycycline attenuates burn-Induced microvascular hyperpermeability

Journal of Trauma and Acute Care Surgery

Volumn 75, Issue 6, 2013, Pages 1040-1046

  Stagg, Hayden Wilson ^a   Whaley, John Greg ^a   Tharakan, Binu ^a   Hunter, Felicia A ^a   Jupiter, Daniel ^a   Little, Danny C ^a   Davis, Matthew L ^a   Smythe, William Roy ^a   Childs, Ed W ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Burn shock; Doxycycline; MMP 9; Rats; Vascular permeability

Indexed keywords

ALBUMIN; BETA CATENIN; DOXYCYCLINE; FLUORESCEIN ISOTHIOCYANATE; GELATINASE B; GELATINASE B INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL PERMEABILITY; BURN; CONFERENCE PAPER; ENZYME ACTIVITY; IMMUNOFLUORESCENCE; LUNG BLOOD VESSEL; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTI-BACTERIAL AGENTS; BURNS; CAPILLARY PERMEABILITY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOXYCYCLINE; ENDOTHELIUM, VASCULAR; MALE; MICROCIRCULATION; MICROSCOPY, VIDEO; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84890094236     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182aa9c79     Document Type: Conference Paper

References (30)

1. American Burn Association. Burn Incidence and Treatment in the United States: 2011 Fact Sheet. Available at: http://www.ameriburn.org/resources- factsheet.php. Accessed October 26, 2011
2. Azzopardi EA, McWilliams B, Iyer S, Whitaker IS. Fluid resuscitation in adults with severe burns at risk of secondary abdominal compartment syndromeVan evidence based systematic review. Burns. 2009;35: 911-920
3. Latenser BA. Critical care of the burn patient: the first 48 hours. Crit Care Med. 2009;37:2819-2826
4. Monafo WW. Initial management of burns. N Engl J Med. 1996;335: 1581-1586
5. Saffle JI. The phenomenon of "fluid creep" in acute burn resuscitation. J Burn Care Res. 2007;28:382-395
6. Tharakan B, Whaley JG, Hunter FA, Smythe WR, ChildsEW. (-)-Deprenyl inhibits vascular hyperpermeability after hemorrhagic shock. Shock. 2010; 33:56-63
7. Whaley JG, Tharakan B, Smith B, Hunter FA, Childs EW. (-)-Deprenyl inhibits thermal injury-induced apoptotic signaling and hyperpermeability in microvascular endothelial cells. J Burn Care Res. 2009;30:1018-1027
8. Demling RH. The burn edema process: current concepts. J Burn Care Rehabil. 2005;26:207-227
9. EversLH, BhavsarD,MailanderP. The biologyof burn injury. ExpDermatol. 2010;19:777-778
10. Huang Q, Xu W, Ustinova E, Wu M, Childs E, Hunter F, Yuan S. Myosin light chain kinase-dependent microvascular hyperpermeability in thermal injury. Shock. 2003;20:363-368
11. Kremer T, Abe D, Weihrauch M, Peters C, Gebhardt MM, Germann G, Heitmann C, Walther A. Burn plasma transfer induces burn edema in healthy rats. Shock. 2008;30:394-400
12. Van den Steen PE, Dubois B, Nelissen I, Rudd PM,Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2002;37: 375-536
13. Luplertlop N, Misse D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, Yssel H, Veas F. Dengue-virusYinfected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep. 2006;7: 1176-1181
14. Cena JJ, Lalu MM, Cho WJ, Chow AK, Bagdan ML, Daniel EE, Castro MM, Shultz R. Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia. Am J Physiol Heart Circ Physiol. 2010;298:H45-H51
15. Fiotti N, Altamura N, Moretti M, Wassermann S, Zacchigna S, Farra R, Dapas B, Consoloni L, Giacca M, Grassi G, et al. Short term effects of doxycycline on matrix metalloproteinases 2 and 9. Cardiovasc Drugs Ther. 2009;23:153-159
16. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple nonantimicrobial mechanisms. Adv Dent Res. 1998;12:12-26
17. Lee H, Park JW, Kim SP, Lo EH, Lee SR. Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia. Neurobiol Dis. 2009;34:189-1989
18. Moses MA, Harper J, Folkman J. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med. 2006; 354:2621-2622
19. Mulivor AW, Lipowsky HH. Inhibition of glycan shedding and leukocyteendothelial adhesion in postcapillary venules by suppression of matrixmetalloprotease activity with doxycycline. Microcirculation. 2009;16: 657-666
20. Palei AC, Zaneti RA, Fortuna GM, Gerlach RF, Tanus-Santos JE. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology. 2005; 56:611-617
21. Reyes R, Guo M, Swann K, Shetgeri SU, Sprague SM, Jimenez DF, Barone CM, Ding Y. Role of tumor necrosis factor-alpha and matrix metalloproteinase-9 in blood-brain barrier disruption after peripheral thermal injury in rats. J Neurosurg. 2009;110:1218-1226
22. Sochor M, Richter S, Schmidt A, Hempel S, Hopt UT, Keck T. Inhibition of matrix metalloproteinase-9 with doxycycline reduces pancreatitisassociated lung injury. Digestion. 2009;80:65-73
23. Fainaru O, Adini I, Benny O, Bazinet L, Pravda E, D'Amato R, Folkman J. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J. 2008;22: 3728-3735
24. Fainaru O, Hornstein MD, Folkman J. Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model. Fertil Steril. 2009;92:1701-1705
25. Walker HL, Mason AD Jr. A standard animal burn. J Trauma. 1968;8: 1049-1051
26. Behzadian MA, Wang XL, Windsor LJ, Ghaly N, Caldwell RB. TGF-beta increases retinal endothelial cell permeability by increasingMMP-9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci. 2001;42:853-859
27. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol. 2004;5:261-270
28. Lampugnani MG, Dejana E. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis. Thromb Res. 2007;120 (Suppl 2):S1-S6
29. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci. 2008;1123:134-145
30. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol. 2008;28:223-2328